Vitiello B
Child and Adolescent Treatment and Preventive Intervention Research Branch, National Institute of Mental Health, Rockville, MD 20857, USA.
Can J Psychiatry. 1998 Aug;43(6):582-4. doi: 10.1177/070674379804300605.
With increasing frequency, psychotropic medications are being prescribed to young children, often for long periods of time. The interaction between psychotropics and the developing brain has not been systematically investigated in humans. Data collected from animals suggest that developing neurotransmitter systems can be exquisitely sensitive to early inhibition or stimulation by pharmacological agents, which can lead to permanent changes in adult life. Most of these data are collected from rodents, and their extrapolation to humans is difficult. More relevant models could be developed for instance using primates. In humans, the focus of research has traditionally been on the possible teratogenic effects of prenatal drug exposure. Recently introduced quantitative imaging techniques can offer new approaches to studying the effects of psychotropics on the developing brain. This research has clear implications for the safety and efficacy of psychopharmacologic drug in children.
越来越频繁地,精神药物被开给幼儿,而且常常是长期用药。精神药物与发育中的大脑之间的相互作用尚未在人类中进行系统研究。从动物身上收集的数据表明,发育中的神经递质系统可能对药物制剂的早期抑制或刺激极为敏感,这可能导致成年后的永久性变化。这些数据大多是从啮齿动物身上收集的,很难将其外推至人类。例如,可以使用灵长类动物开发更相关的模型。在人类中,传统上研究的重点是产前药物暴露可能产生的致畸作用。最近引入的定量成像技术可以为研究精神药物对发育中大脑的影响提供新方法。这项研究对儿童精神药理药物的安全性和有效性具有明确的意义。